CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 144 target
Drug / intervention
hMG-IBSAdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00335894
NCT00335894Phase 3Completed
CompareCT.gov

A Prospective, Randomized, Investigator-blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) vs Menopur (Ferring) Administered s.c. in Women Undergoing COH in an ART Programme (IVF)

IBSA Institut Biochimique SA·interventional·Posted Jun 12, 2006·Updated Mar 10, 2010

In Brief

A Phase 3 clinical trial evaluating hMG-IBSA for Infertility. Completed, enrolled 144 participants across 2 sites.

Detailed Summary

Multicenter, prospective, randomized, investigator blind, controlled clinical trial. Two parallel groups, one receiving the test drug hMG (hMG-IBSA, IBSA Institut Biochimique sa) and the other the reference drug hMG (Menopur, Ferring Pharmaceuticals, Inc.).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesItaly
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 12, 2006
Enrollment StartMay 1, 2005
Primary CompletionMay 1, 2008
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 20.1 years ago

Interventions

hMG-IBSAdrug